bpc-157 lagligt – Research Peptide BPC-157 — Technical Lot Record

The UPLC and Synapt G2-S systems were operated with MassLynx software (Waters, Manchester), data processing and analysis were performed using MarkerLynx XS TM software

In stock Contents: 10 mg lyophilized (freeze-dried) powder provided in a 3 ml vial, sealed and sterile

During the meeting, industry groups said the agency's review did not reflect more recent scientific data on BPC-157 and other compounds, including results from other human studies that had been submitted ahead of time

Key variables in study design include: Route of Administration: Will the compound be studied via systemic injection (subcutaneous, intramuscular) or a more localized injection near the site of injury

Recommendations on opportunities to reduce the number of animals in genotoxicity tests are published by Pfuhler and colleagues in an ECVAM workshop report (Pfuhler et al., 2009)